Literature DB >> 9236410

Chronic variant of myocarditis associated with hepatitis C virus infection.

M Okabe1, K Fukuda, K Arakawa, M Kikuchi.   

Abstract

BACKGROUND: Although molecular biological studies suggest a pathogenic link between enterovirus infection and dilated cardiomyopathy (DCM), the frequency of detection of enteroviral RNA is not consistently high in myocardial tissue from patients with DCM. A recent study has suggested that hepatitis C virus (HCV) may also be involved in the development of DCM. METHODS AND
RESULTS: We performed genomic analysis for HCV in three patients with chronic active myocarditis. In all three patients, serum aminotransferase activities remained within normal ranges until the terminal stage of heart failure. At necropsy, all three livers showed evidence of tissue damage caused by chronic congestion, and one liver had evidence of chronic hepatitis. Routinely processed, paraffin-embedded tissue blocks of myocardium and liver were analyzed. Renal specimens were also analyzed to exclude the possibility of myocardial contamination with HCV material from the circulating blood. RNA extracted from the heart, liver, and kidney was subjected to strand-specific reverse transcription and amplified by semi-nested polymerase chain reaction. The target nucleotide sequence was a 178-bp fragment of the highly conserved 5'-noncoding region. Both positive- (genomic) and negative-strand RNA (replicative intermediates) were present in myocardial and liver tissue samples from all three patients. However, negative-strand RNA was undetectable in renal tissue from one patient.
CONCLUSIONS: These findings suggest that HCV replicated in myocardial tissue of these patients with myocarditis. Thus, HCV infection may contribute to the development of this unusual form of myocarditis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236410     DOI: 10.1161/01.cir.96.1.22

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

2.  Therapy for pediatric myocarditis.

Authors:  Charles E Canter
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

3.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.

Authors:  Fu-Ming Yan; An-Shen Chen; Fei Hao; Xi-Ping Zhao; Chang-Hai Gu; Li-Bin Zhao; Dong-Liang Yang; Lian-Jie Hao
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

5.  Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients.

Authors:  S Navas; J Martín; J A Quiroga; I Castillo; V Carreño
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 6.  An approach to the treatment of pediatric myocarditis.

Authors:  Daniel Levi; Juan Alejos
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 7.  Molecular pathology of inflammatory cardiomyopathy.

Authors:  Karin Klingel; Martina Sauter; C Thomas Bock; Gudrun Szalay; Jens-Jörg Schnorr; Reinhard Kandolf
Journal:  Med Microbiol Immunol       Date:  2003-08-14       Impact factor: 3.402

8.  Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women.

Authors:  Ather Mansoor; Keri Althoff; Stephen Gange; Kathryn Anastos; Jack Dehovitz; Howard Minkoff; Robert Kaplan; Susan Holman; Jason M Lazar
Journal:  AIDS Res Hum Retroviruses       Date:  2009-10       Impact factor: 2.205

9.  Association between chronic hepatitis C virus infection and high levels of circulating N-terminal pro-brain natriuretic peptide.

Authors:  Kyoko Okada; Norihiro Furusyo; Eiichi Ogawa; Hiroaki Ikezaki; Tsuyoshi Ihara; Takeo Hayashi; Mosaburo Kainuma; Masayuki Murata; Jun Hayashi
Journal:  Endocrine       Date:  2012-05-13       Impact factor: 3.633

Review 10.  Immunological alterations in hepatitis C virus infection.

Authors:  Vincenza Calvaruso; Antonio Craxì
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.